Blog
RSS FeedPosted by Michael Wonder on 02 Jun 2017
Transparency Commission revises ASMR for Imbruvica
1 June 2017 - The Transparency Commission has published its revised opinion on the ASMR for ibrutinib for patients with ...
Posted by Michael Wonder on 01 Jun 2017
ACCC 'more aggressive' towards private health insurers
31 May 2017 - The corporate watchdog has made an example of NIB as part of a wider review of ...
Posted by Michael Wonder on 01 Jun 2017
Secukinumab and ixekizumab in psoriasis: significant additional benefit for certain patients
1 June 2017 - The manufacturer of secukinumab has applied for a new benefit assessment as new scientific evidence emerges. ...
Posted by Michael Wonder on 01 Jun 2017
Britain backs first-line use of Merck's Keytruda under cancer fund
31 May 2017 - Britain's cost-effectiveness agency NICE has decided that Merck & Co's immunotherapy drug Keytruda can be used ...
Posted by Michael Wonder on 01 Jun 2017
Laws introduced to 'guarantee' Medicare
1 June 2017 - The Turnbull government insists a new multi-billion dollar fund will guarantee the future of Medicare, amid ...
Posted by Michael Wonder on 01 Jun 2017
NICE backs new drug for Gaucher disease
31 May 2017 - The NICE has issued a positive final appraisal determination recommending Cerdelga (eliglustat) as a first-line treatment ...
Posted by Michael Wonder on 01 Jun 2017
New appointments to the PBAC
1 June 2017 - The Minister for Health has made nine appointments (five new appointments and four re-appointments) to the ...
Posted by Michael Wonder on 31 May 2017
New Zealand Pharmaceutical Schedule - 1 June 2017
1 June 2017 - The June 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 May 2017
NSW kidney patient in desperate plea to drug authority
31 May 2017 - A NSW woman suffering an extremely rare life-threatening disease is praying she will be thrown a ...
Posted by Michael Wonder on 31 May 2017
Schedule of Pharmaceutical Benefits - 1 June 2017
1 June 2017 - The 1 June 2017 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
Posted by Michael Wonder on 30 May 2017
$55,000 spent but hospital funding reform ‘will never be policy’
30 May 2017 - A proposal to pay hospitals in a similar way to Medicare’s funding of GPs has been ...
Posted by Michael Wonder on 30 May 2017
Political roundup: Is the Government spending enough on health?
30 May 2017 - Public health is shaping up to be one of the key battlegrounds of the 2017 general ...
Posted by Michael Wonder on 30 May 2017
National MP urges PHARMAC to consider 'gold standard' neuroendocrine cancer treatment
30 May 2017 - A National MP and chair of Parliament's health committee says it's important PHARMAC consider funding a ...
Posted by Michael Wonder on 30 May 2017
NICE to launch new evidence tool for medtech product developers
30 May 2017 - NICE is launching an online tool to help medtech companies get their products to patients faster. ...
Posted by Michael Wonder on 30 May 2017
Heart failure drug Entresto will be available on Pharmaceutical Benefits Scheme
30 May 2017 - Heart failure hospitalisations cost Tasmania more than $78.5 million a year, according to a new study, ...